Short report: Closing gaps in antiretroviral therapy access: Human immunodeficiency virus-associated dementia screening instruments for non-physician healthcare workers

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 6, 2009, Pages 1054-1059

  Kvalsund, Michelle P ^a   Haworth, Alan ^b   Murman, Daniel L ^c   Velie, Ellen ^d   Birbeck, Gretchen L ^a  

^a East Lansing   (United States)

^b UNIVERSITY OF ZAMBIA   (Zambia)

^c NEBRASKA MEDICAL CENTER   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PREVALENCE; SCREENING TEST; URBAN AREA; ZAMBIA; CROSS-SECTIONAL STUDY; PILOT STUDY;

HUMAN IMMUNODEFICIENCY VIRUS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; ZAMBIA;

EID: 66949114561     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.1054     Document Type: Article

References (24)

1. World Health Organization, 2006. Towards Universal Access by 2010: How WHO is Working with Countries to Scale-up HIV Prevention, Treatment, Care and Support Page. Available at: http://www.who.int/hiv/pub/advocacy/universalaccess/ en/. Accessed March 5, 2008.
2. Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P, 2007. Persistence of neuropsychological deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45: 174-182. (Pubitemid 46869810)
3. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M, 2006. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296: 782-793. (Pubitemid 44223102)
4. Muula AS, Chipeta J, Siziya S, Rudatsikira E, Mataya RHK, Ataika E, 2007. Human resources requirements for highly active antiretroviral therapy scale-up in Malawi. BMC Health Serv Res 7: 208. (Pubitemid 351207866)
5. Kober K, Van Damme W, 2004. Scaling up access to antiretroviral treatment in southern Africa: who will do the job? Lancet 364: 103-107. (Pubitemid 38968632)
6. Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S, 2007. Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol 13: 67-72. (Pubitemid 46510146)
7. Modi G, Hari K, Modi M, Mochan A, 2007. The frequency and profile of neurology in black South African HIV infected (clade C) patients: a hospital-based prospective audit. J Neurol Sci 254: 60-64. (Pubitemid 46343742)
8. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E, 2005. The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS 19: 1367-1374. (Pubitemid 41800672)
9. Power C, Selnes OA, Grim JA, McArthur JC, 1995. HIV dementia scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8: 273-278.
10. Wojna V, Skolasky RL, Hechavarria R, May R, Selnes O, McArthur JC, Melendez LM, Maldonado E, Zorrilla CD, Garcia H, Kraiselburd E, Nath A, 2006. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol 12: 356-364. (Pubitemid 44650048)
11. WHO/UNAIDS, 2004. Epidemiological Fact Sheet on HIV/AIDS and Sexually Transmitted Infections: Zambia Page. Available at: http://www.who.int/ globalatlas/predefinedReports/EFS2004/index.asp. Accessed March 5, 2008.
12. World Health Organization, 1990. Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 65: 221-224.
13. Miller WC, Thielman NM, Swai N, Cegielski JP, Shao J, Manyenga D, Mlalasi J, Lallinger GJ, 1995. Diagnosis and screening of HIV/AIDS using clinical criteria in Tanzanian adults. J Acquir Immune Defic Syndr Hum Retrovirol 9: 408-414.
14. Folstein MF, Folstein SE, McHugh PR, 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
15. Maj M, D'Elia L, Satz P, Janssen R, Zaudig M, Uchiyama C, Starace F, Galderisi S, Chervinsky A, 1993. Evaluation of two new neuropsychologicalal tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol 8: 123-135. (Pubitemid 23079256)
16. Gladstone M, Lancaster G, Jones A, Maleta K, Mtitimila E, Ashorn P, Smyth R, 2007. Can Western developmental screening tools be modified for use in a rural Malawian setting? Arch Dis Child 93: 23-29.
17. Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, 1994. WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychologicalal and neurological findings. Arch Gen Psychiatry 51: 51-61. (Pubitemid 24028998)
18. Sebit MB, 1995. Neuropsychiatric HIV-1 infection study: in Kenya and Zaire cross-sectional phase I and II. Cent Afr J Med 41: 315-322.
19. Belec PL, Testa J, Vohito MD, Gresenguet G, Martin MI, Tabo A, Di Costanzo B, Georges AJ, 1989. Neurologic and psychiatric manifestations of AIDS in Central African Republic [in French]. Bull Soc Pathol Exot Filiales 82: 297-307. (Pubitemid 19207212)
20. Howlett WP, Nkya WM, Mmuni KA, Missalek WR, 1989. Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. AIDS 3: 289-296. (Pubitemid 19167471)
21. Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N, 2007. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68: 350-355. (Pubitemid 46184210)
22. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ, 1999. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13: 1249-1253. (Pubitemid 29361096)
23. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK, 1992. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42: 1472-1476.
24. McGrath NM, Cooke GS, 2007. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 69: 411-412, author reply 412-413. (Pubitemid 47205678)